Qin, S., Li, J., Zhong, H. et al. Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial[J]. Br J Cancer (2022). doi:10.1038/s41416-022-02001-3
British Journal of Cancer
